Nanobiotix (NBTX)

NASDAQ
3.46
-0.24(-6.41%)
  • Volume:
    1,606
  • Day's Range:
    3.45 - 3.51
  • 52 wk Range:
    2.32 - 13.37

NBTX Overview

Prev. Close
3.7
Day's Range
3.45-3.51
Revenue
-
Open
3.5
52 wk Range
2.32-13.37
EPS
-1.35
Volume
1,606
Market Cap
-
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,122
P/E Ratio
-3.07
Beta
2.25
1-Year Change
-67.91%
Shares Outstanding
-
Next Earnings Date
-
What is your sentiment on Nanobiotix?
or
Market is currently closed. Voting is open during market hours.

Nanobiotix News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Nanobiotix Company Profile

Nanobiotix Company Profile

Employees
100

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell